U.S. Wireless Telecom Stock News

Tariffs between the US and Canada are reshaping trade flows in real time, and that ripple effect is starting to reach US industrial stocks. When Canadian exporters face new hurdles, some US producers can gain pricing power or fresh demand, while others risk higher input costs and squeezed margins. This article breaks down how that story plays out in three US industrial stocks that are directly exposed to the latest tariff shock. The stocks in the article below are just a starting sample, and...

Frontdoor stock performance and context Frontdoor (FTDR) has drawn fresh attention after recent trading data showed the stock at $82.89 as of 27 August 2026, with returns reported over the past month and past 3 months. For investors tracking Frontdoor stock, published figures indicate a month return of 14.1% and a past 3 months return of 37.1%, alongside a 1 year total return of 36.4% and a reported value score of 2. The recent 30 day share price return of 14.1% and 90 day share price return...

Qiagen (NYSE:QGEN) has brought its QIAsymphony Connect platform to market, following FDA and EUDAMED listings and initial customer orders, focusing on automated nucleic acid extraction for clinical molecular testing. Qiagen shares trade at US$43.11, and despite a decline in the year to date, the 3 month share price return of 19.15% suggests momentum has picked up recently. The 1 year total shareholder return, down 6.61%, points to a still recovering longer term picture as investors weigh new...

In August 2026, Bitdeer Technologies Group reported that its July hash rate under management reached 81.7 EH/s and self-mined Bitcoin output rose to 990, while also signing a co-mining agreement for 28 MW of equipment at Soluna’s wind-powered Project Kati 1 in Texas. Alongside these mining updates, Bitdeer AI outlined plans to build 350 MW of contracted, customer-funded AI cloud data center capacity by early 2028, pointing to a growing role for AI infrastructure alongside Bitcoin...

Live Oak Bancshares (LOB) has declared cash dividends on both its common and preferred shares, with payments scheduled for September 15, 2026, to shareholders of record as of September 1. At a share price of $40.13, Live Oak Bancshares has had a 30 day share price return that is down 6.24%. However, the 90 day share price return of 7.41% and year to date share price return of 15.62% suggest momentum has been improving over 2026, while the 1 year total shareholder return of 4.07% and 3 year...

Energy markets are back in the spotlight as the Iran war and closure of the Strait of Hormuz disrupt supply routes and keep inflation stubborn around the 3.3% to 3.4% mark. That mix of strong past market performance under Trump, higher volatility, and a major energy shock can reshape how investors think about risk. This article walks through 3 stocks from our global oil and gas screener that appear especially exposed to these headlines. The three stocks below are just a starting sample from...

Short term rates are being pulled in two directions. Regulated stablecoins are funnelling more cash into very short U.S. T bills, while the long end of the curve is still shaped by traditional bond buyers and Treasury buybacks. That split is reshaping how cash like products and duration risk are priced. This article walks through three stocks that appear closely tied to this new, front end focused story. The three stocks that follow are just a starting sample, since the broader screen...

Rhythm Pharmaceuticals has received marketing authorization in Japan for IMCIVREE (setmelanotide) to treat acquired hypothalamic obesity, the first approved therapy in that indication, supported by positive Phase 3 TRANSCEND data showing a statistically significant placebo-adjusted reduction in body mass index. This approval opens a new rare-disease market in Japan, where Rhythm estimates 5,000 to 8,000 people live with acquired hypothalamic obesity, potentially expanding the company’s...

Qualcomm has appointed Sergio Buniac, former President of Motorola Devices, as executive vice president and group general manager of Mobile, Compute and Personal AI, overseeing its smartphone, PC, wearables and XR businesses from September 2, 2026. This hire brings in a leader with deep experience across product, operations and global go-to-market, potentially sharpening Qualcomm’s focus on next-generation AI-enabled devices. We’ll now examine how bringing Sergio Buniac to lead Mobile,...

Recent trading context for Lionsgate Studios stock Lionsgate Studios (LION) has drawn attention after recent trading, with the stock closing at US$11.40 on 26 August 2026. The move comes alongside a decline of about 14% over the past month. Over the past few months, momentum in the Lionsgate Studios share price has faded, with the stock down about 18% over the last 90 days, even though the year-to-date share price return is still about 23% and the 1-year total shareholder return is about...

In late August 2026, NVIDIA reported second-quarter fiscal 2027 results with sales of about US$96.22 billion and net income of roughly US$59.69 billion, issued third-quarter revenue guidance of about US$108 billion, plus or minus 2%, and outlined preliminary expectations for approximately 70% year-over-year revenue growth in fiscal 2028. On top of this earnings strength, NVIDIA and Amazon Web Services disclosed plans to deploy an additional 2 million NVIDIA GPUs across AWS’s global...

Affirm earnings beat and guidance shift investor focus Affirm Holdings (AFRM) is back in the spotlight after its latest fiscal quarter topped expectations on revenue and gross merchandise volume. Management issued guidance that came in above prior forecasts and supported a firmer tone around the stock. Affirm Holdings' latest earnings beat and upbeat guidance sit against a mixed share price backdrop, with a 30 day share price return of 8.74% and a 90 day gain of 6.65%, yet a 1 year total...

City Holding stock performance snapshot City Holding (CHCO) has drawn investor interest after recent trading left the stock at a last close of $143.46. The move comes amid mixed short-term returns and a stronger showing over the past 3 months. Over the past year, City Holding has experienced relatively soft short-term share price returns alongside a stronger upward trend, with the 90-day share price return of 15.99% and the 1-year total shareholder return of 14.78% indicating improving...

nCino (NCNO) stock is in focus after the company paired a return to quarterly profitability with fresh revenue guidance for the third quarter and fiscal 2027, alongside a newly authorized $100 million share repurchase program. That guidance and the move back into the black come after a sharp rebound in nCino’s share price in recent weeks, with a 30 day share price return of 24.54% and a 90 day share price return of 33.74%. However, the 1 year total shareholder return is still down 28.40% and...

Yesway stock moves: recent performance context Yesway (YSWY) has drawn fresh attention after recent share price moves. The stock closed at $24.55 on the latest trading day, and the past month and past 3 months have both shown positive returns. Looking beyond the latest move, Yesway’s recent share price return trends are mixed, with the 7 day share price return down 2.58%, but the 30 day and year to date share price returns at 17.35% and 15.64%, respectively, pointing to building momentum over...

PENN Entertainment recently announced it will invest about US$195 million to relocate its Boomtown Casino & Hotel New Orleans riverboat operations to an adjacent landside site and rebrand the property as Hollywood Casino New Orleans, pending regulatory approval, with plans including 140,000 square feet of new development, roughly 875 slot machines, 45 table games, a retail sportsbook, and multiple dining options. This move, which continues PENN’s pattern of shifting riverboat assets ashore...

Dycom Industries has seen very strong share price gains over the past five years, yet current valuation checks suggest the stock still screens as cheap on both intrinsic value estimates and market multiples. That contrast is front of mind for investors after a sharp pullback in recent weeks. Over the past five years, Dycom Industries has returned about 316.5%, which puts extra focus on whether the current level can be justified by the underlying cash flows. Investor attention today is shaped...

Ingredion has appointed Diego Reynoso, a veteran finance leader from Boston Beer, Tyson Foods and Constellation Brands, as executive vice president and chief financial officer effective October 1, 2026, succeeding interim CFO Jason Payant, who will return to a divisional finance role. Reynoso’s mix of finance and operational experience across large prepared foods and beverage businesses positions him to influence Ingredion’s transformation into a global ingredient solutions provider and its...

Why PTC’s Earnings Miss Still Sparked a Guidance Upgrade PTC (PTC) recently missed fiscal third quarter 2026 earnings and revenue estimates, yet raised the midpoint of its full year annual recurring revenue growth guidance and increased share repurchases, a combination that has quickly refocused investor attention. PTC’s share price has climbed 14.5% over the past month and 8.3% over the past quarter, with much of that move coming after the earnings release and guidance upgrade. However, the...

McCormick stock has had a difficult five year stretch, yet the current intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to a sizeable gap relative to the share price, while market based multiples look closer to in line. That mix leaves investors weighing a possible discount suggested by cash flow modelling against signals that do not show the stock as clearly cheap overall. Over the past five years McCormick shares have fallen about 29.6%, which frames today’s...

Zai Lab and argenx previously reported positive topline Phase 3 ALKIVIA results for VYVGART Hytrulo in adults with autoimmune myositis, showing a statistically significant and clinically meaningful improvement in Total Improvement Score over 52 weeks versus placebo with a safety profile consistent with earlier studies. This success in a disease area with no approved targeted therapies highlights the potential for FcRn inhibition to reshape treatment options across difficult-to-treat...

BioMarin Pharmaceutical stock has delivered a loss of about 30.5% over the past three years, yet the valuation checks currently frame it as looking inexpensive on several fronts. For investors, that gap between weaker long term returns and stronger value signals raises questions about how the market is weighing BioMarin today. Over the past 3 years, BioMarin Pharmaceutical is down about 30.5%, which points to a long stretch of underwhelming shareholder returns despite more recent gains. The...

Veeco Instruments has delivered a strong 5 year share price gain, yet current valuation checks suggest the stock trades at a premium to its estimated intrinsic value and to its usual multiples. For investors, that combination puts more focus on what you are paying today for Veeco Instruments than on the recent share price level alone. Veeco Instruments has returned 89.7% over the past 5 years, which means recent shareholders have already captured a substantial gain from the stock. The...

T1 Energy (TE) is back in focus after securing zoning approval in Mo i Rana, Norway, to develop a data center at its Giga Arctic campus, followed closely by a follow on equity offering. The zoning approval in Norway and the US$160.0m follow on equity offering appear to have refocused attention on T1 Energy, with the stock posting a 14.87% 1 month share price return and an 8.37% 7 day share price return. However, the share price is still down 38.90% year to date and 53.99% over 3 months, while...